Anthracycline chemotherapy, vascular dysfunction and cognitive impairment: burgeoning topics and future directions.
Future Cardiol
; 19(11): 547-566, 2023 09.
Article
en En
| MEDLINE
| ID: mdl-36354315
Cancer and cardiovascular diseases are highly prevalent in the USA and are inter-related issues. Drugs that are used to treat common cancers effectively destroy harmful cancer cells but negatively impact the function of the heart and blood vessels. Cancer patients treated with these drugs are at a high risk of developing problems within the blood vessels that prevent the vessels from dilating properly. Cancer treatments are also associated with impaired memory and brain function later in life. It is important to understand how and why these cancer treatments increase the risk of developing cardiovascular diseases and cognitive impairment. Current research is examining the mechanisms (i.e., potential therapeutic targets) underlying the negative effects of these drugs with the goal of developing interventions and additional treatments to improve the quality of life of cancer survivors.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
/
2_ODS3
Problema de salud:
1_doencas_nao_transmissiveis
/
2_muertes_prematuras_enfermedades_notrasmisibles
Asunto principal:
Enfermedades Cardiovasculares
/
Disfunción Cognitiva
/
Neoplasias
Tipo de estudio:
Risk_factors_studies
Aspecto:
Patient_preference
Límite:
Humans
Idioma:
En
Revista:
Future Cardiol
Asunto de la revista:
CARDIOLOGIA
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos